Chromatographic technology in antibody purification and its progress

Huili LU,Dongqiang LIN,Shanjing YAO
DOI: https://doi.org/10.11949/j.issn.0438-1157.20171040
2018-01-01
Abstract:Antibody, especially monoclonal antibody has become an important therapeutic drug which has a broad market demand and prospect.Nowadays the bottleneck of antibody production has shifted from antibody expression to downstream processing.The typical antibody purification process starts with protein A affinity chromatographic to capture the antibody and includes two subsequent polishing steps for impurity removal, such as ionic exchange, hydrophobic interaction or hydroxyapatite chromatography.There are some limitations restricting the development in antibody industry.Therefore, the researchers are committed to develop novel purification methods, including mixed-mode chromatography (MMC) and short peptide biomimetic chromatography which remedy the weakness of traditional methods.According to the recent advances in the purification of monoclonal antibody drugs, protein A affinity chromatography and the novel chromatographic methods and their applications in monoclonal antibody purification are reviewed in the present article.
What problem does this paper attempt to address?